CXCL1 and breast cancer: Both breast cancer cells treated with CXCL1 exhibited an increase in yellow and free red puncta with increasing doses, while the CXCL1 neutralizing antibody prevented the onset of autophagy induced by TAMs-CM (Fig. 2E).